Unknown OBSERVATIONAL NCT03641105

Investigation of the Contents and Prognostic Values of Glucose Metabolism Molecules in Patients With Lung Adenocarcinoma

Sponsor: Shanghai Zhongshan Hospital

Conditions Diagnosis Glycolysis Lung Cancer Survival

Updated 5 times since 2018 Last updated: Aug 18, 2018 Started: Jan 1, 2014 Primary completion: Mar 1, 2019 Completion: Mar 1, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03641105, this observational or N/A phase trial focuses on Diagnosis and Glycolysis and remains ongoing. Sponsored by Shanghai Zhongshan Hospital, it has been updated 5 times since 2014, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Sep 2020 — Jan 2021 [monthly]

Unknown Status

Status: Active Not Recruiting → Unknown Status
Sep 2018 — Sep 2020 [monthly]

Active Not Recruiting

First recorded

Jan 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shanghai Zhongshan Hospital

Data source: Shanghai Zhongshan Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.